At a glance
- Originator Wakamoto
- Class Antiglaucomas
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 08 Jan 2001 No-Development-Reported for Glaucoma in Japan (Ophthalmic)
- 20 Feb 1997 Phase-III clinical trials for Glaucoma in Japan (Ophthalmic)